[CH2:1](OS(C)(=O)=O)[CH2:2][CH2:3][CH3:4].[N:10]1([C:16]2[C:17](=[O:34])[N:18]([CH2:22][CH2:23][O:24][C:25]3[CH:30]=[C:29]([F:31])[C:28]([F:32])=[CH:27][C:26]=3[F:33])[CH:19]=[CH:20][N:21]=2)[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1.Cl.N1(C2C(=O)N(CCOC3C=C(F)C(F)=CC=3F)C=CN=2)CCNCC1.C(=O)([O-])[O-].[K+].[K+]>CS(C)=O.CCOC(C)=O.O>[F:33][C:26]1[CH:27]=[C:28]([F:32])[C:29]([F:31])=[CH:30][C:25]=1[O:24][CH2:23][CH2:22][N:18]1[CH:19]=[CH:20][N:21]=[C:16]([N:10]2[CH2:15][CH2:14][N:13]([CH2:1][CH2:2][CH2:3][CH3:4])[CH2:12][CH2:11]2)[C:17]1=[O:34]Methanesulfonic acid butyl ester (0.30 g, 1.97 mmol; from Step 1) was added to a mixture of 3-(1-piperazinyl)-1-[2-(2,4,5-trifluorophenoxy)ethyl]-2(1H)-pyrazinone (0.50 g, 1.4 mmol; from the free base of Example 3) and potassium carbonate (0.10 g, 2.89 mmol) in DMSO (3 g). After being stirred for 3 h at 60° C., water (50 g) and EtOAc (100 g) were added to the reaction mixture. The layers were separated and the organic layer was concentrated in vacuo. The residue was purified by chromatography on a MPLC column using a continuous gradient (0-100% EtOAc in heptane) as eluent. This furnished 33 mg (8%) of the title compound as an oil. 1H NMR analysis supports the stated structure. HPLC purity: 100%. HRMS m/z calcd for C20H25F3N4O2 (M)+ 410.1930, found 410.1920.